参考文献/References:
[1] 王坚,邬剑军,常颖,等.中国帕金森疾病蓝皮书[J].中国临床神经科学,2024,32(z1):1-41.
[2] Rey F,Ottolenghi S,Zuccotti GV,et al.Mitochondrial dysfunctions in neurodegenerative diseases: role in disease pathogenesis, strategies for analysis and therapeutic prospects[J].Neural Regen Res,2022,17(4):754-758.
[3] Colpman P,Dasgupta A,Archer SL.The role of mitochondrial dynamics and mitotic fission in regulating the cell cycle in cancer and pulmonary arterial hypertension: implications for Dynamin-Related protein 1 and mitofusin2 in hyperproliferative diseases[J].Cells,2023,12(14):1897.
[4] Shirakabe A,Zhai P,Ikeda Y,et al.Drp-1 dependent mitochondrial autophagy plays a protective role against pressure overload-induced mitochondrial dysfunction and heart failure[J].Circulation,2016,133(13):1249-1263.
[5] Ji Y,Leng Y,Lei S,et al.The mitochondria-targeted antroxidant MitoQ ameliorates mitochondrial ischemia-reperfusion injury by enhancing PINK1/Parkin-mediated mitophagy in type 2 diabetic rats[J].Cell Stress Chaperones,2022,27(4):353-367.
[6] Rai P,Janardhan KS,Meacham J,et al.IRGM1 links mitochondrial quality control to autoimmunity[J].Nat Immunol,2021,22(3):312-321.
[7] Xu JJ,Du W,Zhao YH,et al.Mitochondria targeting drugs for neurodegenerative diseases-design, mechanism and application[J].Acta Pharm Sin B,2022,12(6):2778-2789.
[8] Angelova PR,Abramov AY.Role of mitochondrial ROS in the brain:from physiology to neurodegeneration[J].FEBS Lett,2018,592(5):692-702.
[9] Chan DC.Mitochondrial dynamics and its involvement in disease[J].Annu Rev Pathol,2020,15:235-259.
[10] Roca-Portoles A,Tait SWG.Mitochondrial quality control: from molecule to organelle[J].Cell Mol Life Sci,2021,78(8):3853-3866.
[11] Quintana-Cabrera R,Scorrano L.Determinants and outcomes of mitochondrial dynamics[J].Mol Cell,2023,83(6):857-876.
[12] Zerihun M,Sukumaran S,Qvit N.The Drp1-mediated mitochondrial fission protein interactome as an emerging core player in mitochondrial dynamics and cardiovascular disease therapy[J].Int J Mol Sci,2023,24(6):5785.
[13] Banerjee R,Mukherjee A,Nagotu S.Mitochondrial dynamics and its impact on human health and diseases: inside the DRP1 blackbox[J].J Mol Med(Berl),2022,100(1):1-21.
[14] 赵亮,邱蕾,谷长平,等.线粒体动力相关蛋白1在炎症性肺实质疾病中的作用机制及研究进展[J].国际麻醉学及康复杂志,2023,45(02):190-195.
[15] 汪洋,詹启敏.BRCA1的泛素连接酶活性与肿瘤[J].医学分子生物学杂志,2006,3(5):375-378.
[16] Kim L,Rodriguez ES,Lemasters JJ.Selective degradation of mitochondrial by mitophagy[J].Arch Biochem Biophy,2007,462(2):245-253.
[17] Onishi MS,Yamano K,Sato M,et al.Molecular mechanisms and physiological functions of mitophagy[J].EMBO J,2021,40(3):e104705.
[18] Yao RQ,Ren C,Xia ZF,et al.Organelle-specific autophagy in inflammatory disesses:a potential therapeutic target underlying the quality control of multiple organelles[J].Autophagy,2021,17(2):385-401.
[19] Oliver D,Reddy PH.Dynamics of dynamin-related protein 1 in Alzheimer's disease and other neurodegenerative diseases[J].Cells,2019,8(9):961.
[20] 吴静,聂祖琼,尹琬凌.miR-499通过Drp1介导线粒体自噬保护缺氧/复氧心肌细胞[J].实用医学杂志,2023,39(17):2196-2203.
[21] Place DE,Lee SJ,Kanneganti TD.PANoptosis in microbial infection[J].Curr Opin Microbiol,2021,59:42-49.
[22] 包晨,刘超,刘倩,等.泛凋亡和感染性疾病研究进展[J].华中科技大学学报(医学版),2023,52(4):569-573.
[23] Zeng C,Duan FQ,Hu J,et al.NLRP3 inflammasome-mediated pyroptosis contributes to the pathogenesis of non-ischemic dilated cardiomyopathy[J].Redox Biol,2020,34:101523.
[24] Zheng M,Kanneganti TD.The regulation of the ZBP1-NLRP3 inflammasome and its implications in pyroptosis, apoptosis, and necroptosis(PANoptosis)[J].Immunol Rev,2020,297(1):26-38.
[25] Lin QS,Chen P,Wang WX,et al.RIP1/RIP3/MLKL mediates dopaminergic neuron necroptosis in a mouse model of Parkinson disease[J].Lab Invest,2020,100(3):503-511.
[26] 陈涛,唐北沙,廖小平.α-突触核蛋白在帕金森病发病机制中的作用[J].中华神经科杂志,2006,39(6):415-418.
[27] Cui C,Hong H,Shi Y,et al.Vancomycin pretreatment on MPTP-induced Parkin's disease mice exerts neuroprotection by suppressing inflammation both in brain and gut[J]. J Neuroimmune Pharmacol,,2022,http://pubmed.ncbi.nlm.nih.gov/35091889.
[28] 潘慧琴,张然,荣爽,等.帕金森病重要致病基因致线粒体功能损伤的机制研究进展[J].中华神经科杂志,2022,55(9):1025-1033.
[29] 张美美,冯涛.α-突触核蛋白致病机制研究进展[J].中华神经科杂志,2020,53(3):227-231.
[30] Bailey J,Shaw A,Fischer R,et al.A novel role for endothelial tetrahydrobiopterin in mitochondrial redox balance[J].Free Radic Biol Med,2017,104:214-225.
[31] Dilsizoglu Senol A,Samarani M,Syan S,et al.α-Synuclein fibrils subvert lysosome structure and function for the propagation of protein misfolding between cells through tunneling nanotubes[J].PLoS Biol,2021,19(7):e3001287.
[32] Toyofuku T,Okamoto Y,Ishikawa T,et al.LRRK2 regulates endoplasmic reticulum-mitochondrial tethering through the PERK-mediated ubiquitination pathway[J].EMBO J,2020,39(2):e100875.
[33] Wang XL,Yan MH,Fujioka H,et al.LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1[J].Hum Mol Genet,2012,21(9):1931-1944.
[34] Mir R,Tonelli F,Lis P,et al.The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human[J].Biochem J,2018,475(11):1861-1883.
[35] Chen X,Kordich JK,Williams ET,et al.Parkinson's disease-linked D620N VPS35 knockin mice manifest tau neuropathology and dopaminergic neurodegeneration[J].Proc Natl Acad Sci U S A,2019,116(12):5765-5774.
[36] Wang WZ,Wang XL,Fujioka H,et al.Parkinson's disease-associated mutant VPS35 causes mitochondrial dysfunction by recycling DLP1 complexes[J].Nat Med,2016,22(1):54-63.
[37] Zhi LT,Qin Q,Muqeem T,et al.Loss of PINK1 causes age-dependent decrease of dopamine release and mitochondrial dysfunction[J].Neurobiol Aging,2019,75:1-10.
[38] McLelland GL,Soubannier V,Chen CX,et al.Parkin and PINK1 function in a vesicular trafficking pathway regulating mitochondrial quality control[J].EMBO J,2014,33(4):282-295.
[39] Han H,Tan J,Wang R,et al.PINK1 phosphorylates Drp1(S616)to regulate mitophagy-independent mitochondrial dynamics[J].EMBO Rep,2020,21(8):e48686.
[40] Eberhardt EL,Ludlam AV,Tan ZY,et al.Miro:a molecular switch at the center of mitochondrial regulation[J].Protein Sci,2020,29(6):1269-1284.
[41] Cao J,Chen XB,Jiang L,et al.DJ-1 suppresses ferroptosis through preserving the activity of S-adenosyl homocysteine hydrolase[J].Nat Commun,2020,11(1):1251.
[42] Liu Y,Ma XP,Fujioka H,et al.DJ-1 regulates the integrity and function of ER-mitochondria association through interaction with IP3R3-Grp75-VDAC1[J].Proc Natl Acad Sci U S A,2019,116(50):25322-25328.
[43] 李淑华,陈海波.帕金森病疾病修饰治疗进展[J].中国实用内科杂志,2023,43(10):822-826.
[44] Chen H,Wang S,Ding JH,et al.Edaravone protects against MPP+-induced cytotoxicity in rat primary cultured astrocytes via inhibition of mitochondrial apoptotic pathway[J].J Neurochem,2008,106(6):2345-2352.
[45] Wang WW,Han RY,He HJ,et al.Administration of quercetin improves mitochondria quality control and protects the neurons in 6-OHDA-lesioned Parkinson's disease models[J].Aging,2021,13(8):11738-11751.
[46] Bido S,Soria FN,Fan RZ,et al.Mitochondrial division inhibitor-1 is neuroprotective in the A53T-α-synuclein rat model of Parkinson's disease[J].Sci Rep,2017,7(1):7495.
[47] 周鸿雁,张德元,申存周,等.siRNA沉默Drp1对鱼藤酮诱导的帕金森病模型细胞自噬和凋亡的影响[J].临床和实验医学杂志,2018,17(11):1121-1125.